China Deal Flow has a full time team of 25 Industry and BD professionals at your disposal.
Jeremy Kelly
International CHC and Personal Care industry experience in Sales Marketing and BD with L’Oreal Reckitt GSK and Pfizer.
Founded EBM 1993
Over 25 yrs consulting experience in M&A Business Development and Strategic Planning, working for all of the major Consumer Health companies, including GSK Bayer Pfizer J&J Sanofi Novartis & BI, in N America Latam EU CEE MEA and Apac, across all major therapeutic categories.
Tony Chu
Over 20 years of cross-border transaction experience in US/EU and Chinese chemical and pharmaceutical industries.
Founder and Managing Partner of TPP Healthcare
Founder of Zhejiang Phoenix Valley Co Ltd. Founder and Chairman of TPP Technopark. Current Board Member for companies including Eastar Chemical Corp, Hestia (Wuxi), and PT Inodia (Indonesia). And advises numerous publicly listed Chinese pharmaceutical companies and Investment funds.
Luo Xielong
Partner TPP Healthcare, Executive Director of BOAO Asia International Health Forum, Director of Zhejiang Yangtze Delta Pharmaceutical Research and Development Center, Vice Chairman of Chinese Pharmaceutical Enterprises Association
Vice Chairman of Chinese OTC Association (CNMA)
Previously worked as Chairman of Zhejiang Wansheng and Chinese Medical Research Developing Center; President of Beijing Renhe, Hangzhou National Biology Pharmaceutical Investment Corporation and Beijing Medical University Yikang Technology Development Corporation and Shenzhen Yizhou Hightech Industry; Vice president of HK Yizhou Corporation
Jason Kalik
International CHC industry experience in Sales Marketing and BD Ciba Geigy, Hoechst Marion Rousell, Novartis and Pfizer.
Founded EBM 1993
Over 25 yrs consulting experience in M&A Business Development and Strategic Planning, working for all of the major Consumer Health companies, including GSK Bayer Pfizer J&J Sanofi Novartis & BI, in N America Latam EU CEE MEA and Apac, across all major therapeutic categories.
Johnson Zhong
Nearly 20 years of regulatory experience, primarily focused in registration of products from Western countries into China. Previous Regulatory Affairs Manager in Hanmi Pharmaceutical and Regulatory Affairs Head in Sandoz/Novartis.
Completed more than 30 products in the development of FDF in the first company. Initiated in the Leaping Tiger program all over the world. First-in-Class experiences such as the initiator of the biosimilar guideline in China, the Pediatric policy initiator, the first oncolytic Virus registration, DPI Gx registration.
Ivan Lo
Founder of Hestia nutrition. Over 22 years of experience in MNCs including Novartis, Pfizer health pharmaceuticals and NUTRICIA medical nutrition. Experience in supply chain, finance, new product management, computer management, market access, product registration, Southeast Asia and Pediatric sales and marketing.
Set up a series of hospital/retail management systems to achieve rapid sales growth. Made Caltrate China’s lead Calcium brand.
Awarded the leading figure of Wuxi high-tech zone in 2018, and won the financial support of the government in R&D.
Evan Zhang
Master of Epidemiology and Biostatistics, Fudan University.
Biotechnology, medical equipment, corporate strategy/sales and marketing topics, worked in Meritco Service as consultant for 2 years and in IMS consulting as senior consultant for 3 years.
Assisted world leading medical device companies to understand market trend and competitor intelligence, evaluating the strength and weakness of main players by portfolio/ product quality/R&D and manufacturer/channel setup and economics/sales and marketing strategy, proposed responses for clients.
Wenguang Fan
Executive Director of SDIC Unity Fund responsible for the investment in biomedical field.
Ph.D. in microbiology, MBA, Peking University
Previously Vice President of China Biochemical Pharmaceutical Industry Association. Previously also worked in Pfizer, Merck, Novartis and other large multinational pharmaceutical enterprises. Also served as vice president of Tonghua Jinma and GM of Beijing Shijia Technology Development Co. Ltd
Shaohong Jin
Previous Deputy Director and Director of drug evaluation center of CFDA. Head of antibiotics of China pharmaceutical and biological products inspection bureau.
Graduated from Chinese Academy of Medical Sciences
Visiting fellow, institute of pharmaceutical research, ministry of health and welfare, Canada and Institute of advanced health, ministry of health, Italy. Won 3 national science and technology progress awards and 8 provincial and ministerial science and technology progress awards.
Dakui Li
Current vice chairman and executive director of Chinese pharmaceutical association. Chairman of hospital pharmacy committee of Chinese pharmaceutical association. WHO advisory committee on drug safety Member.
Graduated from College of pharmacy, Peking University Health Science Center, and department of pharmacy, Peking Union Medical College Hospital
Published more than 50 papers in Chinese and foreign magazines, edited and participated in the compilation and translation of 5 books.